NCT07446855 2026-04-20
PARTHENON
AstraZeneca
Phase 1/2 Recruiting
Clinical Trials
7 trialsNCT06581432 2026-04-17
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Boehringer Ingelheim
Phase 2 Recruiting
NCT04529122 2026-04-06
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test
Hoffmann-La Roche
Recruiting
NCT07160725 2026-03-24
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Recruiting
NCT06725758 2026-01-15
TEADES
Orion Corporation, Orion Pharma
Phase 1/2 Recruiting
NCT07165067 2025-12-29
A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors
AP Biosciences Inc.
Phase 1 Recruiting
NCT06815575 2025-12-17
A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.
Race Oncology Ltd
Phase 1 Recruiting